Distinct Roles for Basal and Induced COX-2 in Podocyte Injury
article
OA: closed
CC0
Abstract
Transgenic mice that overexpress cyclooxygenase-2 (COX-2) selectively in podocytes are more susceptible to glomerular injury by adriamycin and puromycin (PAN). To investigate the potential roles of COX-2 metabolites, we studied mice with selective deletion of prostanoid receptors and generated conditionally immortalized podocyte lines from mice with either COX-2 deletion or overexpression. Podocytes that overexpressed COX-2 were virtually indistinguishable from wild-type podocytes but were significantly more sensitive to PAN-induced injury, produced more prostaglandin E(2) and thromboxane B(2), and had greater expression of prostaglandin E(2) receptor subtype 4 (EP(4)) and thromboxane receptor (TP). Treatment of COX-2-overexpressing podocytes with a TP antagonist reduced apoptosis, but treatment with an EP(4) antagonist did not. In contrast, podocytes from COX-2-knockout mice exhibited increased apoptosis, markedly decreased cell adhesion, and prominent stress fibers. In vivo, selective deletion of podocyte EP(4) did not alter the increased sensitivity to adriamycin-induced injury observed in mice overexpressing podocyte COX-2. In contrast, genetic deletion of TP in these mice prevented adriamycin-induced injury, with attenuated albuminuria and foot process effacement. These results suggest that basal COX-2 may be important for podocyte survival, but overexpression of podocyte COX-2 increases susceptibility to podocyte injury, which is mediated, in part, by activation of the thromboxane receptor.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (51)
- W1584384157 via openalex
- W1985844039 via openalex
- W1990488096 via openalex
- W1990752021 via openalex
- W1997222309 via openalex
- W2017805875 via openalex
- W2018509996 via openalex
- W2021632992 via openalex
- W2023043964 via openalex
- W2023761807 via openalex
- W2025262123 via openalex
- W2032846642 via openalex
- W2034941805 via openalex
- W2036447932 via openalex
- W2046955720 via openalex
- W2051515626 via openalex
- W2056693142 via openalex
- W2060979359 via openalex
- W2061937172 via openalex
- W2061980453 via openalex
- W2072802709 via openalex
- W2076219140 via openalex
- W2082911586 via openalex
- W2084032015 via openalex
- W2084289450 via openalex
- W2085574022 via openalex
- W2086373580 via openalex
- W2092587710 via openalex
- W2095323745 via openalex
- W2099077008 via openalex
- W2106403351 via openalex
- W2108188894 via openalex
- W2108796914 via openalex
- W2111854363 via openalex
- W2119655207 via openalex
- W2119758337 via openalex
- W2128235099 via openalex
- W2130345672 via openalex
- W2132722612 via openalex
- W2135423638 via openalex
- W2148165857 via openalex
- W2157793258 via openalex
- W2160418493 via openalex
- W2165485391 via openalex
- W2171670774 via openalex
- W2182194668 via openalex
- W2275889607 via openalex
- W2363176635 via openalex
- W6634822456 via openalex
- W6694479053 via openalex
- W6707248926 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK